Food News and Research

RSS

Americans concerned about quality of Gulf seafood in view of oil spill

Americans are almost universally aware of the oil spill in the Gulf of Mexico, and they are concerned about its potential impact on the safety of Gulf seafood, according to new data from a continuing survey conducted by the University of Minnesota.

29 Jun 2010

School-based program lowers obesity and risk factors for type 2 diabetes in high risk youth

An intervention in middle schools lowered the obesity rate in students at highest risk for type 2 diabetes, those who started out overweight or obese in sixth grade, an NIH-funded study has found. However, schools that implemented the program did not differ from comparison schools in the study's primary outcome-the prevalence of overweight and obesity combined-which had declined 4 percent in both groups of schools by the end of the three-year study.

29 Jun 2010

Researchers study mechanism of human brain

Because of its intricate organization, figuring out the wiring diagram that explains how the billions of neurons in the brain are connected, and determining how they work together, remains a formidable task.

29 Jun 2010

FDA approves Teva's generic Effexor XR antidepressant

Teva Pharmaceutical Industries Ltd. announced today U.S. Food and Drug Administration (FDA) approval of Venlafaxine HCl ER Capsules, the Company's generic version of Wyeth's antidepressant Effexor XR®. Shipment is expected to commence on July 1, 2010, as per the terms of the 2006 agreement with Wyeth.

29 Jun 2010

Study finds high sugar content in toddler and baby food products

Fifty three percent of food products specifically targeted to babies and toddlers in Canadian grocery stores have an excessive proportion-more than 20 per cent-of calories coming from sugar, according to a new study by University of Calgary professor Charlene Elliott.

29 Jun 2010

MGH, Iacocca Foundation complete Phase I BCG clinical trial in type 1 diabetes

Massachusetts General Hospital (MGH) and the Iacocca Foundation announce today the completion of the Phase I BCG clinical trial in type 1 diabetes, as well as the submission of all safety reports to the U.S. Food and Drug Administration (FDA) and the MGH data safety monitoring boards. Plans for the Phase II clinical study, which will continue the investigation of bacillus Calmette-Guerin (BCG) vaccination as a treatment for people with existing type 1 diabetes, are actively underway.

29 Jun 2010

Rosiglitazone associated with increased risk of serious cardiovascular events compared with pioglitazone

A new study published online today by JAMA shows that among patients age 65 years and older, rosiglitazone (a medication for treating Type 2 diabetes) is associated with an increased risk of stroke, heart failure, and all-cause mortality (death) when compared with pioglitazone (another medication for diabetes). The study was published online today in advance of an upcoming Food and Drug Administration meeting that will review the safety of rosiglitazone. The paper will appear in the July 28 print issue of JAMA.

29 Jun 2010

APP to market Anastrozole 1 mg tablets in U.S.

Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that APP Pharmaceuticals will immediately begin marketing Anastrozole tablets in the U.S., after the U.S. Food and Drug Administration granted approval to market the breast cancer treatment medication to Fresenius Kabi Oncology Limited.

29 Jun 2010

G8 nations commit $5B for maternal, child health; Additional $2.3B committed from other countries, foundations

G8 nations, plus other countries and private organizations, have committed at total of $7.3 billion to improve maternal and child health in the developing world, Canadian Prime Minister Stephen Harper said on Friday at the group's summit in Canada's Muskoka region, All Headline News reports (6/26).

29 Jun 2010

EpiCept requests FDA priority review of Ceplene NDA for AML

EpiCept Corporation announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Ceplene® (histamine dihydrochloride). EpiCept is seeking approval for Ceplene, administered concomitantly with low-dose interleukin-2 (IL-2), for the remission maintenance and prevention of relapse in patients with Acute Myeloid Leukemia (AML) in first complete remission.

29 Jun 2010

Shrink Nanotechnologies, Lydall enter technology integration and development agreement

Shrink Nanotechnologies, Inc., an innovative nanotechnology company developing products and licensing opportunities in the solar energy production, medical diagnostics and sensors, and biotechnology research and development tools businesses, announced today that it has entered into a technology integration and development agreement with Lydall, Inc..

29 Jun 2010

FDA's consumer health information on bottled water

Consumers have a big thirst for bottled water. The International Bottled Water Association says that more than 8 billion gallons of it were consumed worldwide in 2009 alone.

29 Jun 2010

FDA's acceptance for filing of DM-1796 NDA triggers $10M milestone payment to Depomed

Depomed, Inc. today announced that it has received a $10 million milestone payment from Abbott Products, Inc., its licensee of DM-1796, for the U.S. Food and Drug Administration's acceptance for filing of the New Drug Application (NDA) for DM-1796 for the management of postherpetic neuralgia (PHN), or pain after shingles.

29 Jun 2010

Cell>Point completes cancer diagnostic phase 2 trial; reports favorable trends in primary tumor imaging

Cell>Point announced today that it has closed the Phase 2 portion of its Phase 2/3 trial of 99mTc-EC-G in evaluating patients with non-small cell lung cancer.

29 Jun 2010

SurgiVision's ClearPoint system granted 510(k) clearance for neurological interventional procedures

DARA BioSciences, Inc., announced today that SurgiVision, Inc., a privately held company of which DARA owns 1,613,258 shares and warrants to purchase an additional 405,000 shares, has received 510(k) clearance from the Food and Drug Administration (FDA) to market their ClearPoint system in the United States for general neurological interventional procedures.

29 Jun 2010

FDA accepts for review BioMimetic Therapeutics' Augment Bone Graft PMA application

BioMimetic Therapeutics, Inc. today announced the Food & Drug Administration (FDA) has accepted for review its Premarket Approval (PMA) application for Augment™ Bone Graft for use in foot and ankle fusions in the U.S. The FDA has now filed the application and begun the comprehensive review of the clinical module.

29 Jun 2010

FDA grants AMS clearance for MiniArc Precise Single-Incision Sling System

American Medical Systems® (AMS), a leading provider of world-class devices and therapies for both male and female pelvic health, today announced the Food and Drug Administration (FDA) has cleared the MiniArc® Precise Single-Incision Sling System, a product for the treatment of female stress urinary incontinence (SUI). MiniArc Precise is the next generation sling in the MiniArc family sling system, the number one selling single-incision sling in the United States.

29 Jun 2010

IAVI announces Japanese pledge of $10M for AIDS vaccine research and development

The International AIDS Vaccine Initiative (IAVI) announced today that the Government of Japan pledged a US$10 million grant to support AIDS vaccine research and development over the next five years. The grant, which will be channeled through a newly established World Bank trust fund, is the first of its kind from the Japanese government to IAVI.

28 Jun 2010

Over 90% of U.S. adults consume twice the recommended limit for sodium intake

Less than 10 percent of U.S. adults limit their daily sodium intake to recommended levels, according to a new report, "Sodium Intake in Adults – United States, 2005-2006," published today in CDC's Morbidity and Mortality Weekly Report. The report also finds that most sodium in the American diet comes from processed grains such as pizza and cookies, and meats, including poultry and luncheon meats.

28 Jun 2010

Sunridge International delivers 60 PNT Units and 10,000 disposable rings to BV of China

Sunridge International, announced today that it has completed production and delivery of 60 PNT Units and 10,000 disposable rings to its exclusive distributor, Beijing Vision World Trading Company (BV) of China.

28 Jun 2010

Food News and Research

Americans concerned about quality of Gulf seafood in view of oil spill

School-based program lowers obesity and risk factors for type 2 diabetes in high risk youth

Researchers study mechanism of human brain

FDA approves Teva's generic Effexor XR antidepressant

Study finds high sugar content in toddler and baby food products

MGH, Iacocca Foundation complete Phase I BCG clinical trial in type 1 diabetes

Rosiglitazone associated with increased risk of serious cardiovascular events compared with pioglitazone

APP to market Anastrozole 1 mg tablets in U.S.

G8 nations commit $5B for maternal, child health; Additional $2.3B committed from other countries, foundations

EpiCept requests FDA priority review of Ceplene NDA for AML

Shrink Nanotechnologies, Lydall enter technology integration and development agreement

FDA's consumer health information on bottled water

FDA's acceptance for filing of DM-1796 NDA triggers $10M milestone payment to Depomed

Cell>Point completes cancer diagnostic phase 2 trial; reports favorable trends in primary tumor imaging

SurgiVision's ClearPoint system granted 510(k) clearance for neurological interventional procedures

FDA accepts for review BioMimetic Therapeutics' Augment Bone Graft PMA application

FDA grants AMS clearance for MiniArc Precise Single-Incision Sling System

IAVI announces Japanese pledge of $10M for AIDS vaccine research and development

Over 90% of U.S. adults consume twice the recommended limit for sodium intake

Sunridge International delivers 60 PNT Units and 10,000 disposable rings to BV of China

Enhancing confidence in chemical ionization spectrometry data eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News